Lansing based Bioport says it's confident despite reports that Harvard is developing an anthrax vaccine.
Bioport is the sole producer of the anthrax vaccine and supplies the U.S. Department of Defense.
It's President and C.O.O. says that while it may take years for the Harvard vaccine to hit the market, if receives government approval, the corporation isn't taking any chances.
Bioport is busy developing other biological vaccines and potentially buying other companies with similar business plans to increase its pharmaceutical pipeline.